Aura Biosciences (AURA) Other financing activities (2020 - 2021)
Aura Biosciences (AURA) reported Other financing activities of -$1.4 million for Q4 2021, down 15800.0% on a YoY basis from N/an in Q4 2020, and down 225.97% quarter-over-quarter from $1.1 million in Q3 2021.
Aura Biosciences (AURA) Other financing activities (2020 - 2021) Analysis & Trends
Aura Biosciences has reported Other financing activities for 2 years, with the latest figure at -$1.4 million in Q4 2021.
- For the quarter ending Q4 2021, Other financing activities fell 15800.0% year-over-year to -$1.4 million; the trailing twelve-month figure through Dec 2021 stood at -$15000.0 (changed N/A YoY), and the FY2021 full-year result was -$15000.0, up 55.88% from the prior year.
- Other financing activities for Q4 2021 stood at -$1.4 million, down from $1.1 million in the prior quarter.
- The five-year high for Other financing activities was $1.1 million in Q3 2021, with the low at -$1.4 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Aura Biosciences | 412.10 Mn | 327.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -1.43 Mn |
| Dec 31, 2021 | -1.43 Mn |
| Sep 30, 2021 | 1.14 Mn |
| Sep 30, 2021 | 1.14 Mn |
| Jun 30, 2021 | 289,000.00 |
| Jun 30, 2021 | 289,000.00 |
| Mar 31, 2021 | -9,000.00 |
| Mar 31, 2021 | -9,000.00 |
| Dec 31, 2020 | -9,000.00 |
| Dec 31, 2020 | -9,000.00 |